Last Posted: May 01, 2020
- Cancer DNA blood test gets real-world trial
K Kaiser, Science, May 1, 2020 - Circulating Tumor DNA Testing—Liquid Biopsy of a Cancer
KS Shohdy et al, JAMA Oncology, March 26, 2020 - Liquid biopsy for mutational profiling of locoregional recurrent and/or metastatic head and neck squamous cell carcinoma.
Galot Rachel et al. Oral oncology 2020 Mar 104104631 - Clinical validation of qPCR Target Selector™ assays using highly specific switch-blockers for rare mutation detection.
Arnold Lyle et al. Journal of clinical pathology 2020 Mar - Evaluating the Use of Circulating MicroRNA Profiles for Lung Cancer Detection in Symptomatic Patients
T Fehlmann et al, JAMA Oncology, March 5, 2020 - Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review.
Petit Joel et al. The Journal of surgical research 2019 236184-197 - Opportunities, Challenges, and Prospects in Electrochemical Biosensing of Circulating Tumor DNA and its Specific Features.
Campuzano Susana et al. Sensors (Basel, Switzerland) 2019 Aug 19(17) - Prospective evaluation of NGS-based liquid biopsy in untreated late stage non-squamous lung carcinoma in a single institution.
Heeke Simon et al. Journal of translational medicine 2020 Feb 18(1) 87 - Current applications and challenges of circulating tumor DNA (ctDNA) in squamous cell carcinoma of the head and neck (SCCHN).
Galot Rachel et al. Cancer treatment reviews 2020 Feb 85101992 - Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages.
Guibert Nicolas et al. European respiratory review : an official journal of the European Respiratory Society 2020 Mar 29(155)
.png)
No hay comentarios:
Publicar un comentario